The three members of the Brn-3 family of POU domain transcription factors are found in highly restricted sets of central nervous system neurons. Within the retina, these factors are present only within subsets of ganglion cells. We show here that in the developing mouse retina, Brn-3b protein is first observed in presumptive ganglion cell precursors as they begin to migrate from the zone of dividing neuroblasts to the future ganglion cell layer, and that targeted disruption of the Brn-3b gene leads in the homozygous state to a selective loss of 70% of retinal ganglion cells. In Brn-3b (؊͞؊) mice other neurons within the retina and brain are minimally or not at all affected. These experiments indicate that Brn-3b plays an essential role in the development of specific ganglion cell types.
The retina is a specialized region of the central nervous system with a relatively small number of cell types. Retinal neurons are arranged in three layers: the outer nuclear layer contains photoreceptor cells; the inner nuclear layer contains horizontal, bipolar, and amacrine cells; and the ganglion cell layer contains ganglion cells and displaced amacrine cells. Each of these cell types can be further divided into subtypes that differ in their physiological and morphological properties, and, in the case of ganglion cells, their pattern of central projections. During development, the various retinal neurons are generated by ordered migrations of postmitotic cells from a layer of dividing neuroblasts, a pattern similar to that observed in the generation of cerebral cortical neurons (1) (2) (3) .
In the mammalian retina there are at least 10 different types of ganglion cells (4, 5) . The more common ganglion cell types, especially those with large cell bodies, have been intensively studied. One major group of ganglion cells projects to the lateral geniculate nucleus, forming the first stage of the retinothalamocortical pathway. In primates, where they have been most extensively characterized, these cells are found to have receptive fields that extract information regarding chromatic, spatial, and͞or luminance contrast. Most of the remaining ganglion cells project to midbrain targets that control eye and head movements, and many of these cells respond selectively to moving stimuli. In contrast to the the current wealth of physiological and anatomical knowledge regarding ganglion cell diversity, we know little about the molecular events that control the arrangement, commitment, and differentiation of these cells.
One approach to understanding neuronal development and diversity begins with a definition of the relevant genetic regulatory events. As a step in this direction, we and others have identified three closely related POU domain genes-Brn3a, Brn-3b, and Brn-3c-that are expressed in the retina, in the dorsal root and trigeminal ganglia, and in a small number of midbrain nuclei (6) (7) (8) (9) (10) . (Brn-3a, Brn-3b, and Brn-3c are also referred to as Brn-3.0, Brn-3.2, and Brn-3.1, respectively, in refs. 8 and 10.) Within the retina, each Brn-3 gene is expressed exclusively within subsets of ganglion cells (6, 7) . The Brn-3 genes show sequence similarity to the Caenorhabditis elegans gene Unc-86, which is expressed in a diverse group of neurons and neuronal precursors and is required in a subset of those cells for normal development (11) (12) (13) . Although the function of the Brn-3 genes is as yet unknown, their highly localized patterns of expression suggest that they are involved in the development of particular subsets of neurons. In the present work, we test this hypothesis for Brn-3b by studying the effects of a targeted disruption of this gene.
MATERIALS AND METHODS
Targeted Disruption of the Brn-3b Gene. Mouse Brn-3b genomic sequences were isolated from a genomic DNA library (strain 129͞J) constructed in EMBL3 (14) and using a human Brn-3b gene segment as probe (6) . To generate the gene targeting construct, the downstream HindIII site of the 2.7-kb BamHI-HindIII fragment 5Ј to the Brn-3b gene was replaced with a BamHI site by conversion to a blunt end followed by addition of a BamHI linker. The resulting 2.7-kb BamHI fragment and the 4.5-kb HindIII fragment 3Ј to the Brn-3b gene were inserted in the correct orientation into the BamHI and HindIII sites in the pNeoTK gene targeting vector (L.G., unpublished work) to create the targeting construct. The targeting construct was linearized at a unique Not I site at the edge of the vector, and 25 g of linearized DNA was electroporated into 10 7 AB-1 embryonic stem (ES) cells, which were then selected for resistance to G418 and 1-(2-deoxy-2-fluoro-␤-D-arabinofuranosyl)-5-iodouracil (FIAU). Among 288 resistant ES colonies, 15 contained the expected homologous recombination event as indicated by Southern blot analysis using flanking probes. Two targeted ES clones, b193 and b230, were injected into C57BL͞6J blastocysts to generate chimeric mice, and subsequently the chimeric mice were bred to C57BL͞6J mice to produce heterozygous and homozygous mice for further analysis (15) . Brn-3b (Ϫ͞Ϫ), (ϩ͞Ϫ), and (ϩ͞ϩ) embryos and mice were genotyped by PCR amplification of genomic DNA.
Immunohistochemistry. Immunostaining of dorsal root and trigeminal ganglia, retinal sections, and retinal flat mounts was performed as previously described (6, 7) . Antibodies to Brn3a, Brn-3b, and Brn-3c are described in refs. 6 and 7. Additional antibodies were obtained from the following sources: anti-
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Abbreviations: ES, embryonic stem; mAb, monoclonal antibody; CNS, central nervous system; en, embryonic day n; DAPI, 4Ј, Thy-1, Boehringer-Mannheim; SMI-32, Sternberger Monoclonals; and anti-tyrosine hydroxylase and anti-glutamic acid decarboxylase, Chemicon.
Histology and Anatomy. Semithin and ultrathin sections of optic nerves and retinas were prepared as described in ref. 16 , with the following modifications. Animals were perfused transcardially with phosphate-buffered saline (PBS) followed by 2% paraformaldehyde and 2% glutaraldehyde in PBS. Tissues were postfixed overnight at 4°C in the same fixative. Following three 10-min rinses in 50 mM sodium cacodylate (pH 7.4), they were postfixed at 4°C for 2 hr in 1% osmium tetroxide in 50 mM sodium cacodylate. The fixed tissues were then rinsed in 50 mM sodium cacodylate, dehydrated in graded ethanol solutions, and infiltrated and embedded in epoxy resin. Semithin sections stained with toluidine blue were examined by light microscopy, and ultrathin sections stained with uranyl acetate, by electron microscopy.
Cresyl violet staining of frozen sections was performed as described in ref. 17 . Neuroanatomic assignments were made with reference to refs. 18 and 19. For SYTOX staining, mice were perfused tanscardially with PBS followed by 4% paraformaldehyde in PBS. Following enucleation, eyecups were prepared and were postfixed overnight at 4°C in the same fixative. The eyecups were rinsed three times for 5 min in PBS, and stained with 1 M SYTOX green fluorescent dead cell stain (Molecular Probes, Inc.) in PBS for 5 hr at room temperature. After three 10-min washes with PBS, the wholemount retinas were peeled off and mounted on gelatin-coated microslides with the ganglion cell layer facing up. The density of stained nuclei within the ganglion cell layer was determined in the vicinity of the optic disc, where the density of these cells changes little with direction or eccentricity (20) . Due to the high density of cells within the inner and outer nuclear layers, cell counts for these layers were obtained from 1-m plastic sections rather than from retina whole mounts.
RESULTS AND DISCUSSION
Phenotype of Brn-3b (؊͞؊) Mice. To determine the role of Brn-3b in vivo, mice lacking the Brn-3b gene were generated by homologous recombination in ES cells (Fig. 1 ). Mice that are either homozygous or heterozygous for the mutant allele [Brn-3b (Ϫ͞Ϫ) or (ϩ͞Ϫ), respectively] are indistinguishable from their wild-type [(ϩ͞ϩ)] littermates in viability, growth rate, fertility, gait, and response to handling. These characteristics suggest that in Brn-3b (Ϫ͞Ϫ) and (ϩ͞Ϫ) mice the somatosensory and motor systems are grossly intact. Visual system function is more difficult to assess by inspection, as bilateral enucleation or hereditary retinal degeneration does not produce a noticeable difference in the above characteristics.
Consistent with the inferred normality of somatosensory function, the trigeminal and dorsal root ganglia, which repre- Retinal Ganglion Cell Defects. In contrast to the trigeminal and dorsal root ganglia, specific defects were found within the retinas of Brn-3b (Ϫ͞Ϫ) mice. While the overall structure of the Brn-3b (Ϫ͞Ϫ) retina resembles that of the wild type, retinas from Brn-3b (Ϫ͞Ϫ) mice are on average 20% thinner, due primarily to a decrease in the thickness of the inner plexiform, ganglion cell, and nerve fiber layers. Quantitation of the number of nuclei in each of the retinal layers shows reductions of 30%, 15%, and 10% in the ganglion cell layer, the inner nuclear layer, and the outer nuclear layer, respectively (Figs. 2 and 3 A and B) .
In the ganglion cell layer of both mouse and rat retinas, displaced amacrine cells and ganglion cells each constitute approximately one-half of the cells (20, 21) . As one approach to determining which of these cell types is underrepresented in Brn-3b (Ϫ͞Ϫ) retinas, we immunostained retinas with antiThy-1, which stains the axons and dendrites of all ganglion cells (22) , and with mAb SMI-32, which predominantly labels the axons of large ganglion cells (23) . As seen in Fig. 3 C-F , Brn-3b (Ϫ͞Ϫ) mice show a large reduction in both Thy-1 and SMI-32 immunoreactive processes, suggesting a significant loss of retinal ganglion cells. To characterize the retinal ganglion cells that remain in the Brn-3b (Ϫ͞Ϫ) retina, we examined the distribution within the retina of Brn-3a and Brn-3c proteins, as these are specific markers for ganglion cells. In the wild-type mouse retina, 35% of cells within the ganglion cell layer contain Brn-3a and Brn-3b, and 15% contain Brn-3c (7); Brn-3a and Brn-3b proteins are therefore present in approximately 70% and Brn-3c in approximately 30% of ganglion cells. Double immunolabeling experiments show that the cells expressing Brn-3a and Brn-3b are largely coincident, and that most of the cells expressing Brn-3c also express Brn-3a and Brn-3b (7). As seen in Fig. 3 G-L , in the Brn-3b (Ϫ͞Ϫ) retina, Brn-3b immunoreactivity is absent as expected, and the number of cells containing Brn-3a and Brn-3c is reduced to approximately 15% of the wild-type number. The cells containing Brn-3a and Brn-3c that are present in the Brn-3b (Ϫ͞Ϫ) retina may represent a subpopulation of ganglion cells that do not normally express Brn-3b.
Optic Nerve Defects. Each retinal ganglion cell gives rise to a single axon which exits the eye as part of the optic nerve. We therefore examined the optic nerves in Brn-3b (Ϫ͞Ϫ) and (ϩ͞ϩ) littermates as an independent measure of ganglion cell number and viability. Brn-3b (Ϫ͞Ϫ) mice show a striking reduction in optic nerve diameter that is apparent to the unaided eye (Fig. 4A) . Cross sections of optic nerve show an average reduction of 5-fold in the cross-sectional area in Brn-3b (Ϫ͞Ϫ) mice compared with their wild-type littermates (n ϭ 4) with a range of 3-to 7-fold (Fig. 4 B and C) . As seen in Fig. 4 D and E, Brn-3b (Ϫ͞Ϫ) optic nerves show a distribution of axon diameters and myelination that closely resembles the distribution in the Brn-3b (ϩ͞ϩ) control, but the Brn-3b (Ϫ͞Ϫ) nerve differs in having a 1.5-fold lower density of axons. All of the experiments described above were carried out with the Brn-3b mutant line b230 (Fig. 1) ; homozygous mutant animals from a second independently derived Brn-3b (Ϫ͞Ϫ) line (b193; Fig. 1) showed the same defects when examined for optic nerve diameter, retinal thickness, number of Brn-3a-immunoreactive cells, and anti-Thy-1 stained retinal axons.
These data indicate that Brn-3b (Ϫ͞Ϫ) retinas have a 60-80% reduction in the number of ganglion cells. Since Brn-3b is expressed in approximately 70% of ganglion cells in the wild-type retina, the simplest interpretation of these data is that all of the Brn-3b-expressing cells are missing. In the Brn-3b (Ϫ͞Ϫ) retina, the subset of ganglion cells that remain and express Brn-3a and͞or Brn-3c is likely to be the source of most or all of the remaining axons within the optic nerve.
Analysis of the Inner Retina and Brain. In the central nervous system (CNS), the absence of one population of neurons often leads to secondary losses in populations of input or target neurons. As described above, light microscopic examination revealed a modest decrease in cell number in the outer two layers of Brn-3b (Ϫ͞Ϫ) retinas, perhaps due to a decrease in the availability of postsynaptic targets. To further examine the inner retina, dopaminergic and ␥-aminobutyric acid (GABA)ergic amacrine cells were selectively visualized with anti-tyrosine hydroxylase and anti-glutamic acid decarboxylase antibodies, respectively (Fig. 5) . In contrast to the marked decrease in the number of ganglion cells, the number of tyrosine hydroxylase-immunoreactive amacrine cells appears similar in Brn-3b (Ϫ͞Ϫ) and Brn-3b (ϩ͞ϩ) retinas. Similarly, glutamatic acid decarboxylase immunostaining suggests that a large number of GABAergic amacrine cells are present in both Brn-3b (Ϫ͞Ϫ) and Brn-3b (ϩ͞ϩ) retinas, although individual GABAergic amacrine cells could not be clearly resolved due to their high density and broad arborization. The principal targets of retinal ganglion cell innervation within the brain, the lateral geniculate nucleus, and the superior colliculus were examined by cresyl violet staining of (1996) coronal sections from adult Brn-3b (Ϫ͞Ϫ) and (ϩ͞ϩ) littermates (data not shown). The size and cellularity of both the lateral geniculate nucleus and the superior colliculus appear to be unaffected in Brn-3b (Ϫ͞Ϫ) mice, suggesting that the remaining retinal ganglion cells may provide sufficient innervation to maintain the viability of most or all neurons within these regions. Brn-3b in the Developing Retina. The retinal ganglion cell defects present in Brn-3b (Ϫ͞Ϫ) mice indicate that Brn-3b plays a critical role in the development of these cells. If this role includes initiating the program of ganglion cell differentiation, then Brn-3b protein should be present in developing ganglion cells at or prior to the time of this decision. In the mouse, [ 3 H]thymidine labeling studies show that between embryonic days 11 and 18 (e11 and e18) most ganglion cell precursors become postmitotic and migrate to the future ganglion cell layer at the inner surface of the developing retina (1-3, 24) . In the developing chicken retina, immunostaining with a ganglion cell-specific mAb demonstrates that ganglion cells begin to differentiate shortly after their terminal mitosis while they are still migrating (25, 26) . Immunostaining of the developing mouse retina shows a progressive increase over time in the number of cells containing Brn-3b in the future ganglion cell layer (Fig. 6 ). In the mitotic zone, cells containing Brn-3b first appear at e11, and their numbers increase to a peak at approximately e12-e15, corresponding to the time during which the greatest number of ganglion cells are undergoing their final mitoses and are migrating from this zone. These immunostained cells are likely to represent recently postmitotic ganglion cells en route to the ganglion cell layer, suggesting that Brn-3b acts in the earliest steps in ganglion cell differentiation.
The diminution in ganglion cell number observed in adult Brn-3b (Ϫ͞Ϫ) retinas could reflect either a failure to generate these cells in the developing retina or a failure of these cells to follow the ganglion cell differentiation program. In the latter case, the affected cells might either die or develop into other retinal cell types. To examine these alternate possibilities, developing Brn-3b (Ϫ͞Ϫ) and (ϩ͞ϩ) retinas were examined for the presence of the ganglion cell-specific markers Brn-3a and Brn-3c and for evidence of cell death. Immunostaining of Brn-3b (Ϫ͞Ϫ) and (ϩ͞ϩ) retinas at e13.5, e15.5, e16.5, and P1.5 revealed similar time courses of appearance of Brn-3a and Brn-3c, both of which begin to accumulate at e13.5 (M.X. and J.N., unpublished observations). However, at each time point the Brn-3b (Ϫ͞Ϫ) retinas differ from the (ϩ͞ϩ) controls in showing approximately 1͞5 as many immunostained cells. These data indicate that the reduction in ganglion cell number in Brn-3b (Ϫ͞Ϫ) mice is evident at a very early stage in ganglion cell development. To quantitate the number and location of dying cells, e13.5 and e15.5 retinas were examined following either in situ terminal deoxynucleotidyltransferase (TdT) labeling of fragmented DNA [terminal dUTP nick end labeling (TUNEL) (27) ] or DAPI staining. At e13.5 and e15.5, TUNEL labeling revealed, respectively, an average of 2-3 and 8-9 labeled cells per 10-m retinal section; no difference was observed between Brn-3b (Ϫ͞Ϫ) and (ϩ͞ϩ) retinas. By DAPI staining, fragmented and͞or homogeneously stained nuclei were observed at a frequency of fewer than 1 per 10-m section in e13.5 retinas from either Brn-3b (Ϫ͞Ϫ) or Brn-3b (ϩ͞ϩ) animals. At e15.5, Brn-3b (ϩ͞ϩ) and (Ϫ͞Ϫ) retinas showed, respectively, an average of 5 and 14 fragmented and͞or homogeneously stained nuclei per 10-m section, and most of these were localized to the inner part of the dividing neuroblast layer.
These data indicate that at the peak of ganglion cell genesis (e11-e18), when the number of developing ganglion cells in Brn-3b(Ϫ͞Ϫ) retinas is already greatly reduced, there is little or no increase in cell death in the ganglion cell layer. While the DAPI analysis suggests that in the developing Brn-3b (Ϫ͞Ϫ) (1996) retina there may be an increase in cell death in the inner nuclear layer, we have no evidence for differential cell death by TUNEL staining. These results suggest that in the absence of Brn-3b the affected ganglion cell precursors fail to appear during development and that the modest reduction in cell number in the inner and outer nuclear layers of the mature retina may follow as a secondary effect of reduced ganglion cell number. This hypothesized effect of ganglion cell number on the generation or survival of inner and outer nuclear layer cells might be relevant to the mechanisms involved in programming different retinal cell densities at different eccentricities. The essential role of Brn-3b in the development of a subset of retinal ganglion cells and its early appearance during ganglion cell differentiation are reminiscent of the essential role in C. elegans of Unc-86 in a subset of neurons and neuronal precursors and the rapid appearance of Unc-86 protein within those cells just prior to its time of action (13) . These similarities, together with the similarity in sequence between Unc-86 and the Brn-3 family, suggest that in the vertebrate CNS the Brn-3 genes are part of a genetic regulatory circuit that evolved from a simpler Unc-86-like system. In this regard, it will be of interest to determine whether targeted mutations in the Brn-3a and Brn-3c genes produce related or overlapping developmental defects. Finally, the extreme specificity of Brn-3b expression and activity suggests that many additional transcriptional regulators exist to control the development of specific subsets of CNS neurons.
